| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |